First Drug To Treat Psychosis Linked To Parkinson's Gets FDA Approval

FDA approves the first Parkinson's-related psychosis drug. Nuplazid (pimavanserin) tablets are designed to treat psychosis-related delusions and hallucinations among some patients with Parkinson's disease.